AAV Vector-Mediated Iduronidase Gene Delivery in a Murine Model of Mucopolysaccharidosis Type I: Comparing Different Routes of Delivery to the CNS

被引：0
|
作者：
Belur, Lalitha [1 ]
Nan, Zhenhong [1 ]
Podetz-Pedersen, Kelly M. [1 ]
Fairbanks, Carolyn A. [1 ]
Hanson, Leah R. [2 ]
Frey, William H. [2 ]
Kozarsky, Karen [3 ]
Low, Walter C. [1 ]
McIvor, R. Scott [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Reg Hosp, Alzheimers Res Ctr, St Paul, MN USA
[3] ReGenX Biosci, Washington, DC USA
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
364
引用
收藏
页码：S140 / S140
页数：1
相关论文
共 50 条
  • [21] Intra-articular AAV9 α-iduronidase gene therapy in mucopolysaccharidosis type I canine model
    Kan, Shih-hsin
    Zhang, Haoyue
    Smith, Jodi D.
    Snella, Elizabeth M.
    Afshin, Aminian
    Jens, Jackie K.
    Valentine, Bethann
    Dickson, Patricia I.
    Ellinwood, N. Matthew
    Young, Sarah
    Wang, Raymond Y.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S82 - S83
  • [22] AAV-Mediated Phenotypic Correction of the CNS Manifestations of a Mouse Model of Mucopolysaccharidosis Type I
    Van de Graaf, Benjamin G.
    Wang, Marlene
    Kwaa, Abena
    Hackett, Neil R.
    Crystal, Ronald G.
    Sondhi, Dolan
    MOLECULAR THERAPY, 2014, 22 : S146 - S147
  • [23] AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models
    Albert, Katrina
    Voutilainen, Merja H.
    Domanskyi, Andrii
    Airavaara, Mikko
    GENES, 2017, 8 (02):
  • [24] Murine mucopolysaccharidosis type I: Targeted disruption of the murine alpha-L-iduronidase gene
    Clarke, LA
    Russell, CS
    Pownall, S
    Warrington, CL
    Borowski, A
    Dimmick, JE
    Toone, J
    Jirik, FR
    HUMAN MOLECULAR GENETICS, 1997, 6 (04) : 503 - 511
  • [25] AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System
    Marino, Marika
    Holt, Matthew G.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [26] Gene Delivery AAV Vector Exploits CPP to Better Reach CNS
    Genet. Eng. Biotechnol. News, 2022, 11 (14): : 14
  • [27] Extracellular Vesicles as Enhancers of Virus Vector-Mediated Gene Delivery
    Fitzpatrick, Zachary
    Gyoergy, Bence
    Skog, Johan
    Maguire, Casey A.
    HUMAN GENE THERAPY, 2014, 25 (09) : 785 - 786
  • [28] Adenoviral vector-mediated gene delivery to injured peripheral nerve
    Dijkhuizen, PA
    Pasterkamp, RJ
    Hermens, WTJMC
    De Winter, F
    Giger, RJ
    Verhaagen, J
    JOURNAL OF NEUROTRAUMA, 1998, 15 (06) : 387 - 397
  • [29] HSV vector-mediated gene delivery to the central nervous system
    Maguire-Zeiss, KA
    Bowers, WJ
    Federoff, HJ
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2001, 3 (05) : 482 - 490
  • [30] PHASE I TRIAL OF AAV VECTOR-MEDIATED GENE DELIVERY OF AROMATIC L-AMINO ACID DECARBOXYLASE FOR PARKINSON'S DISEASE
    Muramatsu, Shin-ichi
    Fujimoto, Ken-ichi
    Kato, Seiya
    Asari, Sayaka
    Mizukami, Hiroaki
    Ikeguchi, Kunihiko
    Kawakami, Tadataka
    Urabe, Masashi
    Kume, Akihiro
    Sato, Toshihiko
    Watanabe, Eiju
    Ozawa, Keiya
    Nakano, Ima-haru
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1024 - 1024
12345